Background Few data exist on the comparative safety and immunogenicity of different
COVID-19 vaccines given as a third (booster) dose. To generate data to optimise selection of …

Introduction Although many sepsis biomarkers have shown promise in selected patient groups,
only C-reactive protein and procalcitonin (PCT) have entered clinical practice. The aim of …

Staphylococcus aureus bacteraemia is one of the most common serious bacterial infections
worldwide. In the UK alone, around 12 500 cases each year are reported, with an …

… Martin Llewelyn et al published in July 26th 2017 in the British Medical Journal an article
entitled "The antibiotic course has had its day" (1). The authors refer to the relationship between …

Background Some high-income countries have deployed fourth doses of COVID-19 vaccines,
but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. We …

Objectives Staphylococcus aureus bacteraemia is a common, often fatal infection. Our aim
was to describe how its clinical presentation varies between populations and to identify …

Bacteria pose unique challenges for genome-wide association studies because of strong
structuring into distinct strains and substantial linkage disequilibrium across the genome 1, 2. …

Introduction. During previous viral pandemics, reported co-infection rates and implicated
pathogens have varied. In the 1918 influenza pandemic, a large proportion of severe illness …

Background Strategies to reduce antibiotic overuse in hospitals depend on prescribers taking
decisions to stop unnecessary antibiotic use. There is scarce evidence for how to support …

Bacterial superantigens are potent T cell activators. In humans they cause toxic shock and
scarlet fever, and they are implicated in Kawasaki’s disease, autoimmunity, atopy, and sepsis. …